JPMorgan Chase & Co’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.8M Sell
428,303
-353,891
-45% -$6.44M ﹤0.01% 2387
2025
Q1
$15.5M Buy
782,194
+14,929
+2% +$296K ﹤0.01% 1863
2024
Q4
$13.2M Buy
767,265
+561,310
+273% +$9.63M ﹤0.01% 2037
2024
Q3
$4.12M Sell
205,955
-33,633
-14% -$672K ﹤0.01% 2751
2024
Q2
$2.68M Buy
239,588
+32,707
+16% +$366K ﹤0.01% 2905
2024
Q1
$1.37M Buy
206,881
+20,513
+11% +$135K ﹤0.01% 3379
2023
Q4
$842K Sell
186,368
-964
-0.5% -$4.36K ﹤0.01% 3630
2023
Q3
$671K Buy
187,332
+11,898
+7% +$42.6K ﹤0.01% 3595
2023
Q2
$647K Buy
175,434
+1,210
+0.7% +$4.47K ﹤0.01% 3649
2023
Q1
$577K Sell
174,224
-110,684
-39% -$367K ﹤0.01% 3746
2022
Q4
$1.11M Buy
284,908
+174,912
+159% +$678K ﹤0.01% 3294
2022
Q3
$268K Buy
109,996
+1,902
+2% +$4.63K ﹤0.01% 4041
2022
Q2
$214K Buy
108,094
+28,988
+37% +$57.4K ﹤0.01% 4293
2022
Q1
$144K Buy
79,106
+61,909
+360% +$113K ﹤0.01% 4599
2021
Q4
$24K Buy
+17,197
New +$24K ﹤0.01% 5282
2021
Q3
Sell
-84,099
Closed -$135K 5496
2021
Q2
$135K Buy
84,099
+33,643
+67% +$54K ﹤0.01% 4665
2021
Q1
$88K Buy
50,456
+6,899
+16% +$12K ﹤0.01% 4676
2020
Q4
$85K Buy
43,557
+21,120
+94% +$41.2K ﹤0.01% 4343
2020
Q3
$49K Buy
22,437
+2,186
+11% +$4.77K ﹤0.01% 4281
2020
Q2
$59K Sell
20,251
-2,385
-11% -$6.95K ﹤0.01% 4166
2020
Q1
$65K Buy
22,636
+6,136
+37% +$17.6K ﹤0.01% 4064
2019
Q4
$66K Sell
16,500
-148,029
-90% -$592K ﹤0.01% 4150
2019
Q3
$732K Buy
164,529
+157,020
+2,091% +$699K ﹤0.01% 3204
2019
Q2
$28K Buy
7,509
+1,259
+20% +$4.7K ﹤0.01% 4449
2019
Q1
$24K Sell
6,250
-23,654
-79% -$90.8K ﹤0.01% 4453
2018
Q4
$72K Sell
29,904
-199,095
-87% -$479K ﹤0.01% 4156
2018
Q3
$1.42M Buy
228,999
+81,003
+55% +$503K ﹤0.01% 2974
2018
Q2
$667K Buy
147,996
+108,505
+275% +$489K ﹤0.01% 3320
2018
Q1
$182K Buy
+39,491
New +$182K ﹤0.01% 3750